160 related articles for article (PubMed ID: 21396929)
1. Biochemistry of the human B-type natriuretic peptide precursor and molecular aspects of its processing.
Semenov AG; Seferian KR
Clin Chim Acta; 2011 May; 412(11-12):850-60. PubMed ID: 21396929
[TBL] [Abstract][Full Text] [Related]
2. B-type natriuretic peptide and its molecular precursor in myocardial infarction complicated by cardiogenic shock.
Hejmdal A; Boesgaard S; Lindholm MG; Goetze JP
J Card Fail; 2007 Apr; 13(3):184-8. PubMed ID: 17448415
[TBL] [Abstract][Full Text] [Related]
3. Alternate circulating pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general population.
Lam CS; Burnett JC; Costello-Boerrigter L; Rodeheffer RJ; Redfield MM
J Am Coll Cardiol; 2007 Mar; 49(11):1193-202. PubMed ID: 17367664
[TBL] [Abstract][Full Text] [Related]
4. Comparative value of BNP and NT-proBNP in diagnosis of heart failure.
Fonseca C; Sarmento PM; Minez A; Gonçalves E; Covas R; Dias AR; Pina MJ; Ceia F
Rev Port Cardiol; 2004; 23(7-8):979-91. PubMed ID: 15478324
[TBL] [Abstract][Full Text] [Related]
5. Role for precursor Pro-B type natriuretic peptide in assessing response to therapy and prognosis in patients with decompensated heart failure treated with nesiritide.
Miller WL; Burnett JC; Hartman KA; Hodge DO; Giuliani I; Minard F; Larue C; Jaffe AS
Clin Chim Acta; 2009 Aug; 406(1-2):119-23. PubMed ID: 19523938
[TBL] [Abstract][Full Text] [Related]
6. Determinants of absolute and relative exercise-induced changes in B-type natriuretic peptides.
Maeder MT; Staub D; Surnier Y; Reichlin T; Noveanu M; Breidthardt T; Potocki M; Schaub N; Conen D; Mueller C
Int J Cardiol; 2011 Mar; 147(3):409-15. PubMed ID: 19897258
[TBL] [Abstract][Full Text] [Related]
7. Diversity of molecular forms of plasma brain natriuretic peptide in heart failure--different proBNP-108 to BNP-32 ratios in atrial and ventricular overload.
Nishikimi T; Minamino N; Ikeda M; Takeda Y; Tadokoro K; Shibasaki I; Fukuda H; Horiuchi Y; Oikawa S; Ieiri T; Matsubara M; Ishimitsu T
Heart; 2010 Mar; 96(6):432-9. PubMed ID: 19966110
[TBL] [Abstract][Full Text] [Related]
8. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
Waldo SW; Beede J; Isakson S; Villard-Saussine S; Fareh J; Clopton P; Fitzgerald RL; Maisel AS
J Am Coll Cardiol; 2008 May; 51(19):1874-82. PubMed ID: 18466803
[TBL] [Abstract][Full Text] [Related]
9. Measurement of the pro-hormone of brain type natriuretic peptide (proBNP): methodological considerations and pathophysiological relevance.
Clerico A; Vittorini S; Passino C
Clin Chem Lab Med; 2011 Aug; 49(12):1949-54. PubMed ID: 21867450
[TBL] [Abstract][Full Text] [Related]
10. B-type Natriuretic Peptide circulating forms: Analytical and bioactivity issues.
Yandle TG; Richards AM
Clin Chim Acta; 2015 Aug; 448():195-205. PubMed ID: 26160054
[TBL] [Abstract][Full Text] [Related]
11. BNP in the diagnosis and risk stratification of heart failure.
Moe GW
Heart Fail Monit; 2005; 4(4):116-22. PubMed ID: 16234898
[TBL] [Abstract][Full Text] [Related]
12. [Diagnostic and prognostic value of B-type natriuretic peptides in heart failure or signs of heart failure].
Rutten JH; Boomsma F; Van den Meiracker AH
Ned Tijdschr Geneeskd; 2007 Nov; 151(46):2553-7. PubMed ID: 18074722
[TBL] [Abstract][Full Text] [Related]
13. The effect of glycosylation on plasma N-terminal proBNP-76 levels in patients with heart or renal failure.
Nishikimi T; Ikeda M; Takeda Y; Ishimitsu T; Shibasaki I; Fukuda H; Kinoshita H; Nakagawa Y; Kuwahara K; Nakao K
Heart; 2012 Jan; 98(2):152-61. PubMed ID: 21719557
[TBL] [Abstract][Full Text] [Related]
14. Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy.
Krauser DG; Lloyd-Jones DM; Chae CU; Cameron R; Anwaruddin S; Baggish AL; Chen A; Tung R; Januzzi JL
Am Heart J; 2005 Apr; 149(4):744-50. PubMed ID: 15990762
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure.
Mueller T; Gegenhuber A; Poelz W; Haltmayer M
Heart; 2005 May; 91(5):606-12. PubMed ID: 15831643
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic, prognostic and therapeutic relevance of B-type natriuretic hormone and related peptides in children with congenital heart diseases.
Cantinotti M; Giovannini S; Murzi B; Clerico A
Clin Chem Lab Med; 2011 Apr; 49(4):567-80. PubMed ID: 21288181
[TBL] [Abstract][Full Text] [Related]
17. B-type natriuretic peptide in heart failure.
Moe GW
Curr Opin Cardiol; 2006 May; 21(3):208-14. PubMed ID: 16601459
[TBL] [Abstract][Full Text] [Related]
18. Updating the role of natriuretic peptide levels in cardiovascular disease.
Gopal DJ; Iqbal MN; Maisel A
Postgrad Med; 2011 Nov; 123(6):102-13. PubMed ID: 22104459
[TBL] [Abstract][Full Text] [Related]
19. The biologic variability of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in stable heart failure patients.
O'Hanlon R; O'Shea P; Ledwidge M; O'Loughlin C; Lange S; Conlon C; Phelan D; Cunningham S; McDonald K
J Card Fail; 2007 Feb; 13(1):50-5. PubMed ID: 17339003
[TBL] [Abstract][Full Text] [Related]
20. Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms.
Januzzi JL; Chen-Tournoux AA; Moe G
Am J Cardiol; 2008 Feb; 101(3A):29-38. PubMed ID: 18243855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
